AIC
RVPH

Archer Investment Corporation’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Archer Investment Corporation’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$640 – 1111
2024
Q2 		$640 Hold
25
– – ﹤0.01% 993
2024
Q1 		$1.89K Hold
25
– – ﹤0.01% 901
2023
Q4 		$2.58K Hold
25
– – ﹤0.01% 866
2023
Q3 		$2.44K Buy
+25
New +$2.33K ﹤0.01% 843

Other funds holding RVPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $253M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Archer Investment Corporation's RVPH Position: Q3 2024 in Review

Archer Investment Corporation sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2024, closing a stake of 25 shares — an estimated $640 sold.

Archer Investment Corporation first reported a position in RVPH in Q3 2023 and held it in 4 quarters. The position peaked at $2.58K in Q4 2023. 33 funds tracked by Wall St. Rank hold RVPH as of Q3 2024.

  • Archer Investment Corporation reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2024 after selling out during the quarter.
  • Archer Investment Corporation sold 25 REVIVA PHARMA HLDGS INC shares in Q3 2024, an estimated $640.
  • Archer Investment Corporation first reported a position in REVIVA PHARMA HLDGS INC in Q3 2023 and held it in 4 quarters.
  • Archer Investment Corporation's REVIVA PHARMA HLDGS INC position peaked at $2.58K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2024.

Based on Archer Investment Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.